福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300194 福安药业

已收盘 10-14 15:00:00

{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":3.94,"timestamp":1791961386000,"preClose":3.98,"halted":0,"volume":13396400,"delay":0,"changeRate":-0.0101,"floatShares":968000000,"shares":1190000000,"eps":0.0502,"marketStatus":"已收盘","change":-0.04,"latestTime":"10-14 15:00:00","open":3.97,"high":4.01,"low":3.92,"amount":52989500,"amplitude":0.0226,"askPrice":3.94,"askSize":1788,"bidPrice":3.93,"bidSize":2069,"shortable":0,"etf":0,"ttmEps":0.0502,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":5,"adr":0,"adjPreClose":3.98,"symbolType":"stock","openAndCloseTimeList":[[1791941400000,1791948600000],[1791954000000,1791961200000]],"highLimit":4.38,"lowLimit":3.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":1.08,"roa":"--","peRate":78.486056,"roe":"2.18%","epsLYR":0.06,"committee":-0.03136,"marketValue":4687000000,"turnoverRate":0.0138,"status":1,"floatMarketCap":3815000000},"requestUrl":"/m/hq/s/300194","defaultTab":"news","newsList":[{"id":"2675364943","title":"股市必读：福安药业（300194）10月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675364943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675364943?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:25","pubTimestamp":1791919511,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，福安药业报收于3.98元，上涨0.0%，换手率1.71%，成交量16.58万手，成交额6546.68万元。董秘最新回复投资者： 问一下公司有生产治疗鼠疫的药品吗？公司子公司目前有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围，但临床具体使用何种药物治疗需经医生诊断和进行专业的判断，谢谢！当日关注点交易信息汇总：10月13日主力资金净流出128.39万元，占总成交额1.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400003570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0028","BK0239","BK0060","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362183","title":"福安药业：公司子公司有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675362183?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:12","pubTimestamp":1791875529,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：问一下公司有生产治疗鼠疫的药品吗？谢谢！福安药业回复：根据国家卫健委发布的《鼠疫诊疗方案（2023年版）》，鼠疫临床分为腺型鼠疫、败血性鼠疫、脑膜炎型鼠疫等多个分型，不同分型治疗方案和用药不尽相同，主要用药有链霉素、四环素、氯霉素、庆大霉素、氟硅诺酮类等药物。公司子公司目前有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围，但临床具体使用何种药物治疗需经医生诊断和进行专业的判断，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300019961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674687688","title":"福安药业(300194)10月9日股东户数3.8万户，较上期增加1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674687688","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674687688?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:43","pubTimestamp":1791798205,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年10月9日公司股东户数为3.8万户，较9月30日增加494.0户，增幅为1.32%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至10月9日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年9月30日至2026年10月9日，福安药业区间涨幅为3.6%，在此期间股东户数增加494.0户，增幅为1.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200023702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674000820","title":"福安药业(300194.SZ)：头孢唑林钠获得上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2674000820","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674000820?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:34","pubTimestamp":1791794078,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福安药业(300194.SZ)发布公告，公司全资子公司福安药业集团重庆博圣制药有限公司 (以下简称“博圣制药”)于近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书，该原料药为：“头孢唑林钠”。上述原料药产品获得上市批准将可以在国内上市制剂中使用，将进一步丰富子公司产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","300194","BK0239","BK0060","BK0028","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670097584","title":"股市必读：福安药业（300194）9月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2670097584","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670097584?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:25","pubTimestamp":1790533513,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，福安药业报收于3.84元，下跌1.54%，换手率1.28%，成交量12.42万手，成交额4795.47万元。机构调研要点9月23日业绩说明会公司产品主要出口印度、东南亚、南美等国家和地区。扣除富民银行投资收益减少影响后，2026年上半年净利润为7,656.82万元，同比增长49.03%。截至9月18日，公司股东户数为36,369户。对于参股公司优诺金长效生长激素三期试验进展，公司暂未获悉应披露信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0060","300194","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669597724","title":"福安药业：9月23日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2669597724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669597724?lang=zh_cn&edition=full","pubTime":"2026-09-24 13:04","pubTimestamp":1790226259,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月24日福安药业发布公告称公司于2026年9月23日召开业绩说明会。问：截止9月20日。福安药业2026年中报显示，上半年度公司主营收入8.39亿元，同比下降8.82%；归母净利润9577.48万元，同比下降15.33%；扣非净利润8643.66万元，同比下降16.93%；其中2026年第二季度，公司单季度主营收入4.32亿元，同比下降4.64%；单季度归母净利润4085.85万元，同比下降7.29%；单季度扣非净利润3778.69万元，同比下降1.51%；负债率21.7%，投资收益2037.02万元，财务费用491.78万元，毛利率39.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400019766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300194","BK0132","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669410497","title":"福安药业(300194)9月18日股东户数3.64万户，较上期减少1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669410497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669410497?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:32","pubTimestamp":1790155954,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年9月18日公司股东户数为3.64万户，较9月10日减少611.0户，减幅为1.65%。在化学制药行业个股中，福安药业股东户数低于行业平均水平，截至9月18日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年9月10日至2026年9月18日，福安药业区间跌幅为2.58%，在此期间股东户数减少611.0户，减幅为1.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300030064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667364587","title":"福安药业(300194)9月10日股东户数3.7万户，较上期减少3.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667364587","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667364587?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:39","pubTimestamp":1789465195,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年9月10日公司股东户数为3.7万户，较8月10日减少1294.0户，减幅为3.38%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至9月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月10日至2026年9月10日，福安药业区间跌幅为0.26%，在此期间股东户数减少1294.0户，减幅为3.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0060","BK0132","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667163856","title":"股市必读：福安药业新发布《关于子公司收到药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667163856","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667163856?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:15","pubTimestamp":1789326913,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，福安药业报收于3.81元，下跌1.8%，换手率1.22%，成交量11.81万手，成交额4492.9万元。当日关注点交易信息汇总：9月11日主力资金净流出316.02万元，占总成交额7.03%。公司公告汇总：全资子公司庆余堂收到注射用赖氨匹林药品注册证书，注册分类为化药3类。截至目前，共有11家企业通过或视同通过一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666308542","title":"福安药业：子公司收到注射用赖氨匹林药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2666308542","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666308542?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:03","pubTimestamp":1789113828,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0132","300194","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035322","title":"股市必读：福安药业新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035322","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662035322?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:03","pubTimestamp":1787864600,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告摘要显示，营业收入8.39亿元，同比下降8.82%；归母净利润9577.48万元，同比下降15.33%；经营活动现金流量净额1.84亿元，同比上升200.84%。公司公告汇总：第六届董事会第七次会议审议通过《2026年半年度报告》及其摘要，全体董事签署书面确认意见。公司公告汇总：2026年半年度非经营性资金占用及其他关联资金往来情况显示，对子公司其他应收款期末余额1.92亿元，系借款形成；控股股东及实际控制人无非经营性资金占用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0239","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770469","title":"福安药业最新公告：子公司硫酸艾沙康唑原料药获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770469","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662770469?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:31","pubTimestamp":1787830296,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告称，公司全资子公司福安药业集团重庆博圣制药有限公司近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书，涉及原料药硫酸艾沙康唑。该药物主要用于治疗侵袭性曲霉病和侵袭性毛霉病，获批后可在国内上市制剂中使用，将进一步丰富子公司产品线。但受GMP合规性检查、国家政策及市场环境等因素影响，生产销售时间及具体销售情况存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700046247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0239","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662971013","title":"福安药业（300194）披露2026年半年度报告，8月26日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662971013","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662971013?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:24","pubTimestamp":1787754257,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，福安药业报收于3.99元，较前一交易日上涨0.25%，最新总市值为47.47亿元。该股当日开盘3.95元，最高4.06元，最低3.95元，成交额达1.01亿元，换手率为2.61%。近日，福安药业（集团）股份有限公司披露《2026年半年度报告》。公告显示，本报告期营业收入为839,297,466.77元，较上年同期下降8.82%；归属于上市公司股东的净利润为95,774,808.12元，同比下降15.33%；扣除非经常性损益后的净利润为86,436,552.47元，同比下降16.93%。经营活动产生的现金流量净额为183,979,476.81元，同比上升200.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600053008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279026","title":"图解福安药业中报：第二季度单季净利润同比下降7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662279026?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:38","pubTimestamp":1787740735,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业2026年中报显示，上半年度公司主营收入8.39亿元，同比下降8.82%；归母净利润9577.48万元，同比下降15.33%；扣非净利润8643.66万元，同比下降16.93%；其中2026年第二季度，公司单季度主营收入4.32亿元，同比下降4.64%；单季度归母净利润4085.85万元，同比下降7.29%；单季度扣非净利润3778.69万元，同比下降1.51%；负债率21.7%，投资收益2037.02万元，财务费用491.78万元，毛利率39.59%。财报数据概要请见下图:本文数据来源于福安药业2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600042273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662928777","title":"福安药业(300194)8月10日股东户数3.83万户，较上期增加0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662928777","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662928777?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:45","pubTimestamp":1787737556,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年8月10日公司股东户数为3.83万户，较7月20日增加337.0户，增幅为0.89%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年7月20日至2026年8月10日，福安药业区间涨幅为3.46%，在此期间股东户数增加337.0户，增幅为0.89%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0060","BK0239","BK0028","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658739069","title":"福安药业(300194)8月10日股东户数3.83万户，较上期增加0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658739069","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658739069?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:26","pubTimestamp":1786526803,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年8月10日公司股东户数为3.83万户，较7月20日增加337.0户，增幅为0.89%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.6万户。从股价来看，2026年7月20日至2026年8月10日，福安药业区间涨幅为3.46%，在此期间股东户数增加337.0户，增幅为0.89%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658866909","title":"福安药业：努力做好投资者关系管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2658866909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658866909?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:45","pubTimestamp":1786347911,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业08月10日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000015378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","300194","BK0028","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658262670","title":"股市必读：福安药业（300194）8月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658262670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658262670?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:42","pubTimestamp":1786297331,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，福安药业报收于3.82元，上涨3.52%，换手率3.4%，成交量32.89万手，成交额1.24亿元。董秘最新回复投资者： 公司业绩，股价长期走弱，投资者损失较大，多项合理化建议均被答复暂无计划。公司有哪些维护中小股东权益的实际举措，谢绝套话。当日关注点交易信息汇总：8月7日主力资金净流入838.61万元，占总成交额6.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","300194","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356874","title":"股市必读：福安药业（300194）8月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657356874?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:21","pubTimestamp":1785864069,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，福安药业报收于3.75元，上涨0.0%，换手率2.0%，成交量19.39万手，成交额7312.05万元。董秘最新回复投资者： 董秘您好，市场上如长缆科技等多家上市公司，使用“维护公司价值及股东权益”回购，低位回购作为库存股，后续择机处置，稳定二级市场波动。当日关注点交易信息汇总：8月4日主力资金净流出995.09万元，占总成交额13.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656306832","title":"股市必读：福安药业新发布《关于子公司收到药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656306832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656306832?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:08","pubTimestamp":1785780494,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，福安药业报收于3.75元，上涨1.08%，换手率1.75%，成交量16.97万手，成交额6325.97万元。当日关注点交易信息汇总：8月3日主力资金净流出162.39万元，占总成交额2.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0239","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791983401151,"stockEarnings":[{"period":"1week","weight":0.0231},{"period":"1month","weight":0.0446},{"period":"3month","weight":0.0365},{"period":"6month","weight":-0.0513},{"period":"1year","weight":-0.0751},{"period":"ytd","weight":-0.0897}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38010人(较上一季度增加1.32%)","perCapita":"25476股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":"　　福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是抗生素类、抗肿瘤类、特色专科药类。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号，在行业内具备一定的市场竞争力。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}